Vision Session: The Importance of Collaboration between State Leaders and the Medical Community to Reduce Opioid Abuse

3. Brad Schimel
Wisconsin Attorney General

8. Mercy Medical Center – Oshkosh, WI

11. Dose of Reality Campaign Statistics
• 1,359 bonus and PSA television spots ran for an estimated value
of $340,000 (December 2015-February 2016)
• Online/Mobile Click-Through Rate (CTR) is 0.29.%, which
exceeds national benchmarks of .07% for Public Awareness
programs.
• Average of 10,000+ website users per month
• Average of 17,000+ page views per month
• 86.1% of visits to the site are from new visitors
• YouTube video completion is 31.9% which is almost double the
industry standard for completions

15. Wisconsin Pharmacy Society

16. Wisconsin Dental Association

17. Wisconsin Hospital Association

19. On December 17, 2015, the Wisconsin
hospital Association passed the following
resolution:
“Recognizing that Wisconsin hospitals play an important role in
addressing this public health issue, the Wisconsin Hospital Association
Board of Directors supports the efforts of WHA member hospitals in
raising awareness of this issue, in developing specific strategies to
address the use and abuse of opioids, and creating a culture of change
that is responsive to the growing epidemic of opioid use and abuse in
Wisconsin.
“Hospitals and health systems will support educational programs for their
prescribers regarding the magnitude of the problem, prescribers’ role in
addressing the problem, including patient education, and best clinical
practices. Hospitals and health systems will assess prescribers’ clinical
practice and identify and address opportunities for improvement.”

20. Marquette Dental School

21. Wisconsin State Coalition for
Prescription Drug Abuse Reduction

24. American Society of Addiction
Medicine

25. ASAM Mission Statement
• Connect patients, providers, and others
– Increase access to & improve the quality of addiction treatment;
• Educate physicians, other health care providers & public;
• Advocate for policies that support medical and public
health approaches to addiction as a chronic disease
– Support research & prevention
• Treat patients with addiction through the use of
appropriately trained physicians and clinical
teams
– Using evidence based practices
– The right treatment at the right time
Connect · Educate · Advocate · Treat

26. ASAM Policies
Screening for Addiction in Health Care Settings
• Clinically effective in enhancing health care outcomes.
• Cost-effective in reducing overall healthcare
expenditures.
• Preventive health care intervention of equivalent
importance to other screening interventions, such as
screening for cancer.
• Should be promoted so that it will become part of the
public consciousness of health care.

27. ASAM Policies (cont.)
Prescription Drug Monitoring Programs (PDMPs)
• Can be effective clinical tools in medication
management involving controlled substances, if
adequately funded and clinicians can access data in
real-time across state boundaries.
• PDMP data is health information and should be
protected from release outside of the health care
system.

28. ASAM Policies (cont.)
Treatment
• Any planned, intentional intervention in the health,
behavior, personal and/or family life of an individual
suffering from addiction, which is designed to enable
the affected individual to achieve and maintain
sobriety, physical, spiritual and mental health, and a
maximum functional ability.
• Addiction treatment services are professional
healthcare services offered by addiction professionals
who are licensed or certified to practice in their local
jurisdiction and/or nationally.

29. ASAM Policies (cont.)
Treatment vs. Incarceration
• All inmates should be screened for addiction and
treatment should be provided for all who have
diagnosable substance use disorders.
• Public policies should offer treatment and
rehabilitation in place of criminal penalties for
persons who are suffering from addiction and whose
only offense is possession of a dependence-
producing drug for their own use.

30. ASAM Activities
ASAM as Partner in PCSS MAT Project
• ASAM develops expert content for CME activities made
available for free to physicians and clinicians using MAT.
• ASAM provides over a dozen mentors for the PCSS-MAT
mentoring program. The program pairs experts in
addiction medicine with those new to the field.
• ASAM hosts multiple buprenorphine waiver trainings
across the country as part of the PCSS-MAT project.

31. ASAM Activities
Standards of Care for the Addiction
Specialist Physician
• ASAM’s Practice Improvement and
Performance Measurement Action
Group (PIPMAG) created Standards of
Care to support quality improvement
activities conducted by health care
provider systems, health care quality
entities, medical specialty certification
boards and by individual physicians
monitoring their own performance in
their own practices.

32. ASAM Activities
National Practice Guideline for the Use of
Medications in the Treatment of Addiction
Involving Opioid Use
• Developed to promote evidence-based
clinical treatment of opioid use disorder
and to assist physicians in the decision-
making process for prescribing
pharmacotherapies to patients with
opioid use disorder.
• The guideline and related products are
available at ASAM.org.

33. ASAM Activities
CDC Guideline on Prescribing of Opioids for Chronic Pain
• The Center for Disease Control and Prevention developed
guidelines on the prescribing of opioids for chronic pain.
• ASAM made recommendations on the guideline for the CDC
to:
– expand the target audience beyond primary care physicians;
– include all FDA-approved medications for opioid addiction treatment;
and
– emphasize more research, among others.

34. ASAM Activities
The ASAM Criteria
• Most widely used and comprehensive set of guidelines for
placement, continued stay and transfer/discharge of patients
with addiction and co-occurring conditions.
• Text available (The ASAM Criteria; Treatment Criteria for
Addictive, Substance-Related, and Co-Occurring Conditions, Third
Edition.
• ​CONTINUUM™ provides a computer-guided, structured
interview for assessing and caring for patients with addictive,
substance-related and co-occurring conditions.